Understanding the impact of active dendritic properties on network activity in vivo has so far been restricted to studies in anesthetized animals. However, to date no study has been made to determine the direct effect of the anesthetics themselves on dendritic properties. Here, we investigated the effects of three types of anesthetics commonly used for animal experiments (urethane, pentobarbital and ketamine/xylazine). We investigated the generation of calcium spikes, the propagation of action potentials along the apical dendrite and the somatic firing properties in the presence of anesthetics in vitro using dual somato-dendritic whole-cell recordings. Calcium spikes were evoked with dendritic current injection and high-frequency trains of action potentials at the soma. Surprisingly, we found that the direct action of anesthetics on calcium spikes were very different. Two anesthetics (urethane and pentobarbital) suppressed dendritic calcium spikes in vitro whereas a mixture of ketamine and xylazine enhanced them. Propagation of spikes along the dendrite was not significantly affected by any of the anesthetics but there were various changes in somatic firing properties that were highly anesthetic dependent. Lastly, we examined the effects of anesthetics on calcium spike initiation and duration in vivo using high-frequency trains of APs generated at the cell body. We found the same anestheticdependent direct effects in addition to an overall reduction in dendritic excitability in anesthetized rats with all three anesthetics compared to the slice preparation.
INTRODUCTION
Most of our knowledge of dendritic properties comes from in vitro recordings. The relatively few studies in vivo so far have required the use of urethane, barbiturate or ketamine anesthesia (Hirsch et al., 1995; Svoboda et al., 1997; Helmchen et al., 1999; Larkum and Zhu, 2002; Waters et al., 2003) .
However, these anesthetics, as most other anesthetics, are known to affect ion channel activity and the firing properties of neurons (Urban, 2002; Antkowiak, 2002; Vahle-Hinz and Detsch, 2002; Arhem et al., 2003) . Dendritic data obtained in vivo can therefore only be interpreted after understanding the direct effects of commonly used anesthetics on dendritic excitability.
The choice of anesthetic is always critical when examining neuronal properties in animals. General anesthesia is presumed to result in loss of consciousness but the particular actions at the cellular level are diverse. The main criteria for the choice of anesthetics in this study were their widespread use in rats and water-solubility for comparison to in vitro data. The three anesthetics chosen (urethane, pentobarbital and a mixture of ketamine and xylazine) all belong to different classes. Urethane is a long-acting steady-level anesthetic with myo-relaxant properties. It is advantageous for long experiments requiring few or even no supplemental doses and involves minimal disruption of physiologically relevant measures (Maggi and Meli, 1986; Field and Lang, 1988) . On the other hand it is highly carcinogenic and is rarely used for recovery experiments. Pentobarbital sodium (Nembutal) is a short-acting barbiturate which primarily increases the activity of GABA A receptors in the central nervous system (Drafts and Fisher, 2006) and has a long history of use in neuroscience. Ketamine is a dissociative general anesthetic which has a short duration and fast recovery time with few adverse effects. It is reported to act as a noncompetitive antagonist of NMDA receptors leading to the blockade of glutamatergic neurotransmission (Liu et al., 2006) . It is not recommended for use alone because of its poor analgesic effect and is therefore often used in combination with xylazine, an alpha-2 adrenergic receptor agonist causing sedation and mild analgesia (Schwartz and Clark, 1998) . Beside their principal actions, all of these drugs have diffuse low affinity targets including many of the 
MATERIALS AND METHODS
Animal handling was in strict accordance with the guidelines given by the veterinary office of the canton Bern-Switzerland.
In vitro brain slice preparation. Acute parasagittal brain slices of the primary somatosensory neocortex were obtained from Wistar rats (P35-P56). After decapitation without previous anesthesia the brain was quickly removed into ice-cold, oxygenated (95% O 2 , 5% CO 2 ) Artificial Cerebro-Spinal Fluid (ACSF) solution containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH 2 PO4, 1 MgCl 2 , 25 NaHCO 3 , 2 CaCl 2 , 25 Glucose (pH 7.4, 315-320 mOsmol). Slices (300 µm thick) were cut using a Microm vibratome and kept at 35 ± 0.5°C for 15 minutes and then kept at room temperature until use. Slices were continuously perfused with ACSF during the experiments which were performed at 32 ± 2°C.
In vitro electrophysiology. Whole-cell recordings were performed from L5 pyramidal neurons somata and apical dendrites using thick wall (0.5 mm) borosilicate pipettes with filament (outer diameter 2 mm) (Hilgenberg GmbH, Malsfeld, Germany). Somatic (5-7 M ) and dendritic (12-25 M ) patchclamp electrodes were filled with intracellular solution (in mM): 135 KGluconate, 4 KCl, 10 HEPES, 10 Na 2 -Phosphocreatine, 4 Mg-ATP, 0.3 Na-ATP (pH 7.3, 291-293 mOsmol). For somato-dendritic recordings, 10 µM Alexa 568 and 0.4% biocytin were added in order to facilitate neuron localization and to reconstruct the cell respectively. For cell visualization infrared differential interference contrast optics or oblique illumination with an Olympus microscope (Olympus, Hamburg, Germany) was used and for visualizing Alexa 568 a Texas Red filter set was used.
Patch-clamp recordings were made first in control conditions, perfused with ACSF, and data acquisition was started. Anesthetics (urethane, pentobarbital and ketamine/xylazine) were then added to the extracellular ACSF solution and perfused on the slices for 10 minutes before electrophysiological measurements. Wash-out was determined where possible after the slices had been perfused for at least 10 minutes with normal ACSF. Anesthetics were tested at similar concentrations to previous in vitro studies (Parker et al., 1986; ffrench-Mullen et al., 1993; Friederich et al., 2001; Hara and Harris, 2002; Adelsberger et al., 2005; Schnoebel et al., 2005) . The concentrations (10-20 mM for urethane, 100-200 µM for pentobarbital, 400 µM for ketamine and 50 µM for xylazine) were chosen to be roughly similar but slightly higher than the concentrations injected in vivo, assuming that in vivo the amount injected is equally distributed over the entire body mass. Because urethane was tested at concentrations that may affect osmolarity, glucose in the ACSF was reduced in urethane solutions to keep the osmolarity constant (15 mM and 5 mM glucose for 10 mM and 20 mM urethane, respectively). Electrophysiological recordings were obtained with Dagan BVC-700A amplifiers using Igor Pro software.
In vivo animal preparation. Wistar rats (P28-70) were anesthetized with an intraperitoneal injection of either urethane (1.4 g/kg), pentobarbital sodium (35 mg/kg), or ketamine/xylazine hydrochloride (75 mg/kg, 10 mg/kg respectively). Supplemental doses of about 25% of the initial dose were administrated as needed to keep animals free from pain reflexes. The animal was placed in a stereotaxic frame. All pressure points and incised tissues were infiltrated with 2% lidocaine to reduce pain. Body temperature was measured via a rectal probe (FHC Inc., Bowdoin, ME) and maintained with a homeothermic blanket (FHC Inc., Bowdoin, ME) at 36.5 ± 0.5°C for the surgery and increased to 37.5 ± 0.5°C during the recordings. After clearing connective tissue from the skull, the position of the barrel cortex was stereotaxically determined (3 mm posterior and 5 mm lateral to bregma). A craniotomy (1 x 1 mm) was performed using a high-speed drill (Osada Electric LTD., Tokyo, Japan).
Following removal of the bone, a small incision was carefully created in the dura mater to allow access for the patch pipette.
In vivo electrophysiology. Blind whole-cell patch-clamp recordings (Pei et al., 1991; Margrie et al., 2002) were performed in the barrel cortex in layer 5 at an average subpial depth of 1141 ± 154 µm (STD, n=53). The depth was estimated from the electrode penetration in the brain, taking into account the angle between the cortical surface and the electrode. We used thick-walled borosilicate pipettes with filaments (4-7 M ), filled with the same intracellular solution as in vitro. In some cases we added biocytin (1%) to the intracellular solution in order to identify the cells after the experiment. Out of 15 filled cells, the morphology of 9 could be recovered (see Histology below). All of these cells had somata in L5 and could be identified as pyramidal neurons. The firing pattern was also used as an indication of cell type and cells with firing patterns not corresponding to pyramidal cells (e.g. putative interneurons with very short APs at frequencies >100 Hz) were rejected. An air puff to the contralateral whiskers always evoked a response. Electrophysiological recordings were obtained using the same amplifiers and software as in vitro.
Histology. After the in vitro electrophysiology brain slices were fixed with 4% paraformaldehyde in 0.1 M Phosphate Buffer Solution (PBS) and kept at 4°C. After in vivo electrophysiology the rat was perfused with 4°C 0.1 M PBS followed by 4°C 4% paraformaldehyde in 0.1 M PBS. The brain was removed and kept in 4°C 4% paraformaldehyde in 0.1 M PBS, then sliced at a thickness of 250 µm.
Slices were processed using the avidin-biotin-peroxidase method. Cells then were drawn with a computerized reconstruction system (Neurolucida).
Analysis. The critical frequency protocol is an indirect method to evoke dendritic calcium activity using high-frequency trains of APs evoked at the cell body (Larkum et al., 1999a) (Suppl. Fig. 1 ). The amplitude for a single time point and the integral of the falling phase 5-15 ms after the initiation of the last AP in the somatic train (after-depolarizing potential, ADP) was measured in each neuron at frequencies between 30-250 Hz. Such values were reported as the ADP amplitude and the ADP integral, both notifying similarly the presence of a dendritic calcium spike. The critical frequency (CF) in vitro was defined as the turning point of a sigmoidal fit to the ADP versus frequency curve. The sigmoidal fit is a heuristic used throughout the study to provide a consistent method for estimating the CF. The CF most depends on the summation of backpropagating APs in the initiation zone for calcium spikes {Larkum, 1999 50 /id} and therefore corresponds to the threshold for a calcium spike. The ADP amplitude (and ADP integral) is dependent on the influence of the dendritic Ca 2+ spike on somatic V m and therefore corresponds to the amplitude and/or duration of the calcium spike. In control conditions (ACSF) in vitro an average critical frequency of 98.2 ± 22.4 Hz (STD) and an average ADP amplitude of 6.6 ± 3.0 mV (STD, n=99 L5 pyramidal neurons) was obtained. The CF was stable for at least 30 minutes after patching (Suppl. Fig. 2 ). Because of baseline fluctuations of the signals in vivo, multiple trials (3-10) were averaged. The existence of a critical frequency in vivo was determined through the ADP integral by comparing low and high values on either side of the turning point from a sigmoidal fit (as in vitro) and testing for statistical difference (2-tailed paired t-test). The up states were not specifically segregated from the down states, however data are likely to be biased towards recordings in the down state because traces in which background activity obscured the ADP were not used in the analysis.
Dendritic calcium current was approximated by measuring the voltage-time integral of the calcium spikes evoked by dendritic current injection (50 ms or 1 s duration). The voltage-time integral was calculated as the area underlying the active potential component of the dendritic calcium spike close to threshold. To estimate the active component, the response to current injection was extrapolated from subthreshold traces and subtracted from the suprathreshold traces. The firing properties were assessed by examining the responses to supratheshold depolarizing pulses (1 s) to the soma in vitro and the following parameters were measured: resting membrane potential, rheobase (current threshold), AP peak amplitude, AP half width, input resistance, amplitude of sag, action potential frequency adaptation and "burstiness". Input resistance was measured from the slope of the current/voltage relationship to long current injections (1 s, -300 pA to threshold in steps of 100 pA) using the steadystate region of the response. Amplitude of sag was measured as the percentage of the steady-state response to -300 pA current injection compared to the maximum response. The action potential frequency adaptation was measured for discharges elicited by depolarizing 1 s pulses by calculating the proportional change in the frequency of the last inter-spike interval (ISI) compared to the frequency of the first inter-spike interval. Only discharges with an initial frequency lower than 150 Hz were analysed (Christophe et al., 2005) . We defined a new measure, degree of "burstiness", as the proportion of bursts (trains of APs with inter-spike intervals < 20 ms) in the total number of trains following a long (1 s) step current injection to the soma. We also noted "missing spikes": gaps in otherwise regular spike trains which were multiples of the most frequent ISI. 
RESULTS
The results are summarized as follows: first, we show the direct effect of anesthetics (urethane, pentobarbital and ketamine/xylazine) on calcium spike threshold, amplitude and duration using dual recordings in vitro. We then examine the shift in critical frequency and the change in the afterdepolarizing potential (ADP) amplitude in vitro before and after the application of the anesthetics. We demonstrate that the anesthetics have little influence on AP propagation in the dendrite and that both the CF and change in ADP amplitude are reliable assays of dendritic Ca 2+ spike activation. In addition,
we examine the effect of the anesthetics on basic cellular firing properties using current injection at the soma. Lastly, we measure the critical frequency and ADP in vivo following IP injection of the anesthetics.
I. Effects of anesthetics in vitro

A) Dendritic properties
Dendritic current injection
We first tested the direct effect of commonly used anesthetics on dendritic spike activity. We obtained dual patch recordings from the somata and apical dendrites ( Fig. 1 ) in the region of the calcium spike initiation zone (727.3 ± 117.4 µm from the soma, STD, n=11; Larkum and Zhu, 2002 ). Long depolarizing current pulses (1 s) evoked calcium spikes in the apical dendrite (Fig. 1B) and bursts of APs at the soma (Fig. 1C) . We examined the dendritic calcium spikes before (black traces) and after addition of anesthetics to the extracellular medium (red traces). We measured the voltage-time integral and the current threshold (rheobase) of the first dendritic response following long current injection (1 s) to the dendritic site ( Fig. 1 & 2) . To calculate the regenerative component due to ion channel activity in the voltage-time integral, we subtracted the non-regenerative subthreshold component due to the current injection from the suprathreshold traces. The voltage-time integral of this regenerative component should correspond closely to the net positive influx of charge into the dendrite (Iansek and Redman, 1973) . Interestingly, the anesthetics used had opposing effects on dendritic properties. On the one hand 20 mM urethane and 200 µM pentobarbital significantly reduced the integral by 33.9 ± 8.6%
(n=5) and 42.5 ± 10.4% (n=3), respectively. In one cell, pentobarbital had such a strong effect that we could no longer evoke suprathreshold activity (this cell was excluded from analysis). On the other hand, 400 µM ketamine / 50 µM xylazine had the opposite effect, significantly increasing the integral by 106.5 ± 53.4% (n=4) showing that this combination of anesthetics actually enhances calcium spike activity in the apical dendrite of L5 pyramidal neurons (Fig. 2A&B , Table 1 ). The case shown in Fig. 1A3-C3 was for a cell which by chance had an unusually low level of dendritic Ca 2+ activity in control conditions. In this case, ketamine/xylazine dramatically increased the number of dendritic calcium spikes and their duration. Additionally, pentobarbital significantly increased the current threshold for evoking dendritic regenerativity, whereas ketamine/xylazine significantly decreased the current threshold (by 61.6 ± 9.8%, n=3, 16.6 ± 4.4%, n=4, respectively) ( Fig. 2C ). Despite their effects on threshold and duration, none of the anesthetics significantly changed the peak amplitude of the dendritic calcium spike (Table 1) . Taken together these results show that there are direct effects on the threshold and duration of dendritic calcium spikes which are anesthetic specific, which in turn, have an impact on somatic firing activity.
Reliability of the critical frequency test
Dual dendritic/somatic patch-clamp recordings are currently not feasible in vivo and single dendritic patch-clamp recordings in vivo, while feasible (Larkum and Zhu, 2002; Waters and Helmchen, 2004) tend to be much more difficult and less reliable than somatic recordings. Since our aim was to examine the direct effects of the same anesthetics in vivo, we needed a robust method to test their effect on dendritic activity using somatic patch-clamp recordings. We used the "critical frequency" test (Larkum et al., 1999a) which we show here can be used in vitro as a surrogate for dendritic recordings to determine the effects of anesthetics on dendritic activity (Fig. 3D&E , Suppl Fig 1) . Using this method, the effects of the anesthetics already seen on threshold would be reflected in a change in the critical frequency and the effects on duration would be reflected in a change in the amplitude of the afterdepolarizing potential (ADP). This approach also had the advantage that the site of dendritic patch recording was no longer an arbitrary parameter and that stable long-term recordings could be performed regularly.
To test the reliability of the critical frequency protocol as a measure of the direct effects of anesthetics on dendritic activity we again used dual dendritic/somatic recordings in vitro. Trains of 3-4 backpropagating APs (BPAPs) were generated with short duration current steps (2 ms) at frequencies between 30 Hz and 250 Hz at the soma ( Fig. 3 ). At high frequencies (supra-CFs) there was a dramatic increase in the amplitude and width of the dendritic potential generated near the last BPAP in the train (Fig. 3C , black traces). We used a sigmoidal fit to this dendritic potential amplitude to estimate the critical frequency ( Fig. 3D & E) . A sigmoidal fit to the ADP at the soma at different frequencies revealed a CF which was not significantly different from the CF estimated using the dendritic potential (85.8 ± 2.5 vs 86.1 ± 2.5 Hz; p=0.72; n=11; Fig. 3D&E ). This showed that the CF could be measured accurately with a somatic recording in control conditions. Bath application of the anesthetics (Fig. 3 , red traces) changed the CF, the dendritic depolarization and the somatic ADP amplitude at high frequencies. In the presence of anesthetics, there was still no significant difference between the CF measured at the dendrite or at the soma in each cell (91.9 ± 6.9 vs 92.8 ± 6.7 Hz; p=0.58; n=11; Fig.   1D&E , red traces). We concluded that the CF measured at the soma in vitro accurately determines the effect of the anesthetics.
As with the direct dendritic current injection (Figs. 1 & 2), the anesthetics had opposing effects on the activation of dendritic activity using the critical frequency test measure either at the soma and or the dendrite (Fig. 3) . We found that urethane and pentobarbital tended to increase the CF and to decrease the somatic ADP amplitude, both indications of an inhibitory effect on Ca 2+ spike generation. On the other hand, ketamine/xylazine decreased the CF and increased the somatic ADP amplitude, indicating an enhancing effect on Ca 2+ spike generation (Fig. 3D&E ). The data from direct dendritic current injection (Figs. 1 & 2) suggest that the anesthetics had direct effects on the initiation and duration of the dendritic Ca 2+ spike.
Effect of anesthetics on the propagation of action potentials along the dendrite
We also investigated the effect of the anesthetics on the amplitude and half-width of BPAPs in the apical dendrite, as well as the integral of the dendritic potential of the train of BPAPs. There was no significant effect on the amplitude nor the half width of the dendritic BPAP by either urethane or pentobarbital relative to the somatic AP (a change by +1.5 ± 1.7%; n=5 and +1.0 ± 3.2% respectively; n=3; Table 1 ) (a change by -5.2 ± 3.4 %, n=5 and -8.0 ± 7.5%, n=3; Table 1 ). Ketamine/xylazine also had no significant effect on the amplitude of the BPAPs (a change by -12.1 ± 7.9%) nor on the BPAPs half width (a change by +32.5 ± 16.5%; n=3; Table 1 ) relative to the somatic AP. However, both the amplitude and duration of the somatic AP were affected by ketamine/xylazine. (The corresponding effects on somatic APs for all anesthetics are discussed in detail below and shown in Table 2 ). The fidelity of propagation along the dendrite could also, in principle, affect the summation of the BPAPs in the distal tuft region. We found that there were no significant effects of the anesthetics on the integral of the BPAPs measured in the dendrite at sub-CFs (Fig. 4 , light gray bars), showing that the anesthetics did not change the integration of BPAPs per se. In contrast, the integral of the BPAPs at supra-CFs changed significantly after application of each anesthetic (Fig. 4 , dark gray bars) The effect of ketamine/xylazine on integration of BPAPs was complicated by the change in the shape of the somatic AP. Here, the decrease in amplitude coupled with an increase in half width are likely to have had opposing effects on the integral measured in the dendrite. Nonetheless, even in this case, the effect of ketamine/xylazine was only significant for supra-CF BPAPs. Taken together, these data show that the anesthetics affect the generation of Ca 2+ spikes in the dendrite (and in the case of ketamine/xylazine the generation of Na + spikes at the soma/axon) but do not affect the propagation of APs along the dendrite. that ketamine/xylazine had the opposite effect to urethane and pentobarbital. Similarly, the somatic ADP amplitude was decreased by 10.7 ± 5.7% in urethane (Fig. 5D&H) , by 54.0 ± 7.5% (n=12) in pentobarbital ( Fig. 5E&H ) and increased by 151.0 ± 19.3% (n=14) in ketamine/xylazine (Fig. 5F&H ).
Effect of anesthetics on dendritic activity evoked by
Thus, our conclusions remained the same: that urethane and pentobarbital inhibited the generation of dendritic calcium spike, while ketamine/xylazine enhanced it.
Lower concentrations of anesthetics had partially similar effects. 10 mM urethane significantly increased the CF (by 12.5 ± 1.8 % of control, n=11, p<0.001) but did not affect the somatic ADP amplitude (a change by -10.4 ± 5.5 % of control, n=11, p=0.18). 100 µM pentobarbital, on the other hand did not significantly alter the CF (a change by -2.8 ± 1.9% of control, n = 10) but decreased the somatic ADP amplitude (by 15.9 ± 5.8% of control, n=10, p<0.05). In a few experiments we used a very high concentration of pentobarbital (1 mM) which had such large depressive effects on somatic spike generation and propagation that the effects on CF couldn't be tested. We tested ketamine and xylazine on their own and the mixture of ketamine/xylazine was tested at respective lower concentrations of 40 µM/5 µM and 100 µM/12.5 µM. 400 µM ketamine alone on 2 neurons out of 2 decreased the CF by 13.9% of control on average and increased the somatic ADP amplitude by 87.9% of control. 50 µM xylazine alone did not significantly decrease the CF (by 10. 
B) Somatic firing properties
Anesthetics have been reported to affect the basic firing properties of neurons (Antkowiak, 1999; Christophe et al., 2005; Sceniak and Maciver, 2006) . We tested the effect of urethane, pentobarbital and ketamine/xylazine on AP firing properties using long (1 s) step-current injection at the soma (Fig.   6 ). We analysed a number of parameters and particularly those that might be related to dendritic properties ( Fig. 7 , Table 2 ). For instance, burst firing in pyramidal neurons can be an indication of dendritic activity (Wong and Prince, 1978; Helmchen et al., 1999; Williams and Stuart, 1999; Schwindt and Crill, 1999; Larkum et al., 1999b) . We determined the change in burstiness with 10 mM and 20 mM urethane in vitro. Under control conditions, the average burstiness of cells was 37.8 ± 6.8% (n=16), which indicates that normally ~1/3 of the spike trains were in the form of bursts. While there was a slight decrease from control (37.8 ± 6.8% , n=16) to 20 mM urethane (29.2 ± 6.7%, n=16), this was not statistically significant. There was also no significant difference in the number of "missing spikes" in a train which gave another measure of the "irregularity" of a train (see Methods). We found a small difference in the threshold of the APs with 20 mM urethane (-41.32 ± 1.6 mV, n=16 versus -43.97 ± 1.2 mV, n=16 under control conditions, p<0.05) (Fig. 7D) . In general urethane appeared to have minor effects and preserved the firing properties quite well compared to the other anesthetics tested.
Pentobarbital (100 or 200 µM) did not alter the degree of burstiness. However pentobarbital (unlike urethane and ketamine/xylazine) lead to a specific firing behavior in which the spike trains appeared to be interrupted (i.e. single spikes appeared to be missing in otherwise regular trains of APs). This pA, n=10, p<0.05 and 658.3 ± 72.5 pA, n=12, p<0.001, respectively) was increased compared to control conditions (363.9 ± 40.6 pA, n=12) ( Table 2 ). To reach threshold with 200 µM pentobarbital we needed to increase the amplitude of current injected by 80.9%. With 100 and 200 µM pentobarbital the input resistance (30.2 ± 2.6 M , n=10, p=0.13 and 24.7 ± 1.7 M , n=12, p<0.01, respectively) was decreased compared to control conditions (35.3 ± 3.6 M , n=12) (Fig. 7A) . The AP frequency adaptation increased from the control conditions (10.8 ± 6.5%, n=8) to 200 µM pentobarbital (41.8 ± 11.4%, n=9, p<0.01). With 1 mM pentobarbital firing was either abolished completely or only one or two APs occurred at very high thresholds (n=8, data not shown). Under such conditions we could not properly use the critical frequency protocol. We concluded that pentobarbital depressed sodium APs generation, likely through the increasing of ion channel conductances.
With 400 µM/50 µM ketamine/xylazine (but not for lower concentrations), burstiness increased from 16.1 ± 8.9% under control conditions to 51.2 ± 7.5%, n=14, p<0.05 (Figs. 6B & 7C) , a relative increase by 35.1%. This is consistent with the enhancement by ketamine/xylazine of dendritic calcium spike regenerativity. Another specific feature of 400 µM/50 µM ketamine/xylazine was a progressive decrease in the amplitude of the APs in a train and this decrease became stronger with increased current injection. This AP amplitude adaptation was observed in 92.9% (n=14) of the neurons and did not exist in control conditions nor for lower concentrations tested. Ketamine/xylazine also increased the AP frequency adaptation (from 30.1 ± 7.7%, n=11 in control conditions to 86.5 ± 2.3%, n=10, p<0.001) as well as the APs half width (from 0.757 ± 0.037 ms to 0.836 ± 0.048 ms, n=14, p<0.01) (Fig. 7E) . Ketamine/xylazine also decreased the peak amplitude of the first AP in a train (from 89.7 ± 4.4 mV in control conditions to 65.3 ± 3.0 mV, n=14, p<0.001) (Fig. 7F) . The AP threshold was depolarized from -42.6 ± 1.2 mV in control conditions to -37.2 ± 1.5 mV (n=14, p<0.001) with ketamine/xylazine (Fig. 7D ) and the resting membrane potential was hyperpolarized from -67.0 ± 0.7 mV to -68.9 ± 1.1 mV, n=14, p<0.05. In other words, ketamine/xylazine had a double impact on neurons. On the one hand ketamine/xylazine enhanced dendritic properties, resulting in an increase in burstiness at the soma. On the other hand ketamine/xylazine inhibited the generation of somatic APs.
Among the three anesthetics tested in vitro, urethane affected the firing properties the least and ketamine/xylazine the most. Such information might be important in the context of functional studies at the network level. For this study the salient point was that there was a general correspondence between the effects of the anesthetics on dendritic properties and on somatic firing properties:
pentobarbital depressed both dendritic calcium spikes and sodium APs generation, whereas ketamine/xylazine enhanced dendritic calcium spikes and increased burstiness.
II. Effects of anesthetics in vivo
We wanted to test the direct effects of anesthetics on the generation of Ca 2+ spikes in vivo and to compare dendritic excitability with the in vitro data. We recorded from L5 pyramidal neurons in vivo at depths of 825-1500 µm from the pial surface (average 1141 µm ± 154 µm, STD, n=53) using the blind patch clamp technique (Pei et al., 1991; Zhu and Connors, 1999; Larkum and Zhu, 2002) . The intraperitoneal doses of anesthetic injected to the rats were 1.4 g/kg for urethane, 35 mg/kg for pentobarbital, 75 mg/kg of ketamine mixed to 10 mg/kg of xylazine. As in vitro, we evoked trains of 3-4 BPAPs and recorded the critical frequency, the ADP amplitude and calculated the ADP integral (Fig. 8) . Resting membrane potentials tended to fluctuate more in vivo due to greater background activity. In many cases, the CF could still be determined from a single trial (i.e. one measurement of the ADP for each frequency across a given range), however in cases of high activity, we took the average of several (3-10) trials. To calculate the CF, we measured the ADP at frequencies between ~30-250 Hz. This is referred to in the paper as a "trial". Occasionally in vivo we recorded more than once at each frequency (3-10 times), and this is still referred to as one trial.
In vitro, nearly all L5 pyramidal neurons showed a CF for ADP enhancement and the CF was robustly reproducible from trial to trial. In contrast, we found that the CF was not always detectable in vivo (Fig. 9A ). On the other hand, none of the anesthetics abolished the CF in all cells. Our criterion in vivo for attributing a CF to a cell was a p<0.05 significance value when performing a t-test on the points either side of the mid-point of a sigmoidal fit. Under urethane anesthesia, in 14 neurons out of 19 (73.7%) the ADP amplitude varied sharply around a critical frequency. Under pentobarbital and ketamine/xylazine this proportion decreased slightly to 62.5% (n=16) and 66.7% (n=21). Even in cells that showed a CF there were trials (where the ADP was measured across a range of frequencies) in which no CF could be detected (Fig. 9B ). The rate of occurrence for the CF from trial to trial in vivo was 64.7% (n=34 trials) for urethane, 56.1% (n=57 trials) for pentobarbital and 40.7% (n=54 trials) for ketamine/xylazine (Fig. 9B ). This variability suggested that some additional factor inhibits the dendritic Ca 2+ spikes in vivo which would be consistent with fluctuations in inhibition impinging on the dendrite since inhibition is known to strongly suppress dendritic Ca 2+ spikes (Pérez-Garci et al., 2006) . Note that the anesthetics which had the least effect on somatic firing properties in vitro had the highest occurrence of the CF in vivo and vice versa.
Using two-way ANOVA we found that there was a statistically significant increase in the CF in vivo compared to in vitro (p<0.001, df=1, n=78; Fig. 10A ) and no interaction of this factor with the variable anesthetic, i.e. the trend was the same in vivo compared to in vitro. This provided evidence that the direct effects of the anesthetics on dendritic properties observed in vitro, were also present in vivo.
Interestingly, ketamine/xylazine did not lower the CF proportionately as much in vivo as in vitro
presumably because the enhancement of Ca 2+ spikes by ketamine/xylazine competed with the general suppression of Ca 2+ spikes in vivo.
In vivo, we found that both the ADP amplitude and the ADP integral over 10 ms (starting 5 ms after the initiation of the last AP) could be used to determine the influence of the dendritic Ca 2+ spike on the soma (Fig. 8D-F) . However, because of the random fluctuations in membrane potential in vivo, it was difficult to find a single time point at which to compare all the data in vivo and in vitro to establish the relative amplitude of the ADP. We therefore chose the ADP integral for comparisons made across cells in vivo and in vitro (Fig. 10B ). Using this measure we found that the average ADP integral for each anesthetic was lower in vivo compared to in vitro but due to the huge difference in the case of ketamine/xylazine, the trend was not found to be similar using two-way ANOVA. As with the CF, we assume that the suppressive effects on dendritic Ca 2+ activity in vivo counteracted the direct action of ketamine/xylazine. This disproportionately large counteractive effect is consistent with the lower occurrence of detectable CFs in vivo with ketamine/xylazine. Another possible explanation for the discrepancy observed for ketamine/xylazine in vivo vs in vitro could be that the final concentration obtained in vivo is small. This possibility is unlikely given the fact that even with an order-ofmagnitude reduction in vitro, the facilitatory effect of ketamine/xylazine could still be detected.
Nontheless, in order to further test this possibility, we made additional experiments with local cortical application of 400 µM/50 µM ketamine/xylazine at the site of craniotomy (i.e. the highest concentration used in the slice). There was no further increase with 400 µM/50 µM ketamine/xylazine added to the surface of the cortex compared to the control condition in which the rat was only anesthetized with IP injection (n=6; p = 0.89 & p = 0.86 for the CF and ADP respectively). Thus, the discrepancy observed for ketamine/xylazine in vivo vs in vitro was unlikely related to the concentration of ketamine/xylazine present in vivo. In summary, we conclude that the direct effects of the anesthetics present in vitro are also present in vivo competing with (or adding to) a general tendency for the suppression of dendritic Ca 2+ activity in vivo.
DISCUSSION
We investigated the effect of the anesthetics urethane, pentobarbital and a mixture of ketamine/xylazine on dendritic properties in L5 pyramidal neurons in vitro and in vivo. There were five main conclusions: 1) all three anesthetics tested altered the initiation and duration of dendritic calcium spikes: urethane and pentobarbital suppressed dendritic activity whereas ketamine/xylazine enhanced it. 2) All three anesthetics had negligible effects on the amplitude and shape of BPAPs 3)
Each anesthetic had particular effects on the somatic firing properties. 4) The direct effects of the anesthetics were similar in vivo to in vitro and 5) there was some additional factor or factors in vivo which further suppressed dendritic Ca 2+ activity. Although all anesthetics alter the level of consciousness, their specific actions on channel conductances and receptors both pre-and postsynaptically can be quite different (Franks and Lieb, 1994; Dilger, 2002; Richards, 2002; Rojas et al., 2006) . Even the choice of anesthetic concentration in vitro can be problematic (Franks, 2006) and there is a lack of specificity at higher concentrations with most anesthetics. On the other hand, our principal aim was to investigate their effects specifically on intrinsic dendritic excitability with a view to interpreting studies of dendritic properties in vivo rather than to understand the mechanisms underlying the ability of anesthetics to occlude consciousness. In principle we cannot know the precise concentrations of the drugs in the cortex in vivo, however we chose concentrations of anesthetics which have been used in other studies in vitro (Accorsi-Mendonca et al., 2007) .In addition using several concentrations, we found no evidence that the inhibitory versus facilitatory effect on Ca 2+ spikes was concentration dependent.
Our study further confirmed that urethane, pentobarbital and ketamine/xylazine had quite different specific actions both in their effects on somatic and dendritic firing properties. By using direct current injection, the effects of the anesthetics on intrinsic dendritic excitability were investigated. However in the case of synaptic stimulation anesthetics may affect the calcium spike differently. The specific action of anesthetics on dendritic voltage-sensitive channels will require further study and is in general influence AP shape and propagation. This will likely require focusing on each anesthetic in turn in separate studies in vitro. Ketamine/xylazine had the opposite effect on dendritic firing properties compared to urethane and pentobarbital. Although, urethane and pentobarbital had similar effects on dendritic properties, their effects on somatic firing properties were different and even the underlying dendritic mechanisms of action may have been different. Below we speculate on the mechanisms likely to be involved based on effects determined in our study and by others using somatic recordings.
Urethane
Urethane is one of the most commonly used anesthetics in research on rodents, partly because of its long-lasting action (Maggi and Meli, 1986) . Although most anesthetics are thought to enhance inhibition in the cortex, urethane has one of the lowest effects on GABAergic transmission (Scholfield, 1980) , but the underlying mechanisms are not completely understood. Urethane has been reported to inhibit NMDA and AMPA receptors in a concentration dependent manner, to potentiate the functions of neuronal nicotinic acetylcholine and glycine receptors, but also to have variable effects on GABAergic neurotransmission (Garrett and Gan, 1998; Hara and Harris, 2002; Accorsi-Mendonca et al., 2007) . Our results suggest that 10-20 mM urethane inhibited dendritic excitability, which is in agreement with Adelsberger et al. (2005) who showed that urethane suppressed calcium waves in brain slices and in vivo. We saw very little change in most cellular firing properties (e.g. input resistance, AP amplitude and width, spike adaptation) which is in agreement with Sceniak and MacIver (2006) and Accorsi-Mendonca et al. (2007) . We did however observe a significant shift of the AP threshold to more depolarized values accompanied with a slight increase in the rheobase, which suggests that urethane depressed action potential discharge. Sceniak and MacIver (2006) also described a strong depression of potential discharge accompanied with a decrease in membrane resistance which they attributed to selective activation of a Ba 2+ -sensitive K + leak conductance. Moreover, urethane has also been shown to suppress the Na v 1.2 channel function (Shiraishi and Harris, 2004) .
Pentobarbital
The principle action of pentobarbital is its enhancement of GABAergic transmission (Parker et al., 1986; Macdonald et al., 1989; Drafts and Fisher, 2006) . However, pentobarbital has also been reported to act on many other targets including inhibition of voltage-activated Ca 2+ channel currents (ffrenchMullen et al., 1993; Todorovic and Lingle, 1998; Todorovic et al., 2000; Kitayama et al., 2002) , depression of glutamate-mediated excitatory synapses (Pittson et al., 2004) and inhibition of sodium channels (Wartenberg et al., 1999) . All these targets seem consistent with the inhibition pentobarbital exerts on calcium spikes, but it is not clear yet which effects prevail. We found that pentobarbital had a similar action to urethane in suppressing dendritic activity. However, the effects of pentobarbital on general firing properties were stronger than urethane, including an increase in the rheobase, decrease in input resistance and a general hyperpolarization of the resting membrane potential. This would be consistent with a tonic activation of GABA A activity by pentobarbital (Farrant and Nusser, 2005) . It would also explain the discontinuities occuring in the spike trains of APs and the powerful blockade of firing at higher concentrations. Consistent with previous reports (Antkowiak, 1999), we found that pentobarbital inhibited spontaneous AP firing in a concentration dependent manner. However, Christophe et al. (2005) showed that a proportion of L5 pyramidal neurons switched from regular firing to intrinsic bursting mode due to prolonged pentobarbital anesthesia in vivo prior to recordings in vitro. Such differences could have resulted from homeostatic effects of the anesthetic on intrinsic membrane properties.
Ketamine/xylazine
The most unexpected result of our study was that a mixture of ketamine and xylazine in vitro enhanced dendritic excitability with a broadening of the Ca 2+ spike, a lowering of the critical frequency and a corresponding increase in ADP amplitude. Ketamine is a dissociative anesthetic whose main action is as a non-competitive antagonist of NMDA receptors (Hirota and Lambert, 1996; Kapur and Seeman, 2002) . At low doses and during emergence from anesthesia, ketamine is known to have various psychotomimetic effects which account for its use as a recreational drug (Krystal et al., 1994; Rowland, 2005) . Used in combination with xylazine, it is a very common alternative to urethane and pentobarbital in animal experiments (Green et al., 1981) . Apart from its main anesthetic action on NMDA channels there is evidence that ketamine enhances GABA A receptors (Scholfield, 1980; Gage and Robertson, 1985; Irifune et al., 2000) although others have reported that it does not interact with these receptors (Hirota and Lambert, 1996; Yamakura et al., 2000; Kitayama et al., 2002; Lingamaneni and Hemmings, Jr., 2003) . In addition, ketamine can inhibit various voltage-sensitive channels including sodium, calcium and potassium channels (Hara et al., 1998; Zhou and Zhao, 2000; Friederich et al., 2001; Hatakeyama et al., 2001; Kitayama et al., 2002; Schnoebel et al., 2005) . This makes it very difficult to predict its action on dendritic activity.
Adding to the complexity are the effects of xylazine which principally activates 2 -adrenergic receptors (Cabral et al., 1998) . The effects we observed on broadening dendritic Ca 2+ spikes are consistent with studies showing that ketamine prolonges the total duration of plateau-like cardiac APs (Hatakeyama et al., 2001 ) and that xylazine enhances myometrial contractility mediated by 2 -adrenergic receptors and calcium channels (Ko et al., 1990) . A recent study showed that 2 -receptors down-regulate I h channels colocalized on the dendrites of cortical pyramidal neurons (Wang et al., 2007) . Inhibition of I h channels has been shown to enhance dendritic Ca 2+ channel activity and decrease the critical frequency (Berger et al., 2003) and xylazine might act on Ca 2+ channel activity through this pathway. Ketamine/xylazine had the greatest effect on firing properties of all three anesthetics. Christophe et al. (2005) measured a switch from regular firing to intrinsic bursting mode in L5 pyramidal neurons with prolonged ketamine/xylazine anesthesia previous to decapitation which was similar to the effects we observed. Interestingly however, they did not observe similar effects in vitro with bath application of ketamine (10-200 µM).
Critical frequencies in vivo were systematically higher than in vitro for all anesthetics. This strongly suggests that some additional factor in vivo affects the threshold for dendritic Ca 2+ activity. One possibility is due to inhibition arising from network activity not present in vitro (Rudolph et al., 2007) .
GABAergic transmission has a strong veto-like action on dendritic activity (Pérez-Garci et al., 2006) .
Moreover, most anesthetics recruit additional inhibition (Franks and Lieb, 1994) . On the other hand,
we did observe evidence of dendritic Ca 2+ activity with all anesthetics which is consistent with previous reports in vivo using urethane, pentobarbital, thiopental and ketamine anesthesia (Hirsch et al., 1995; Helmchen et al., 1999; Zhu and Connors, 1999; Larkum and Zhu, 2002 ) .
In conclusion, we have presented the first study identifying dendritic calcium spikes as a direct target of anesthetics. All the drugs tested here affecting consciousness also had direct effects on dendritic Ca 2+ spikes and firing properties although the specific effects were quite different. Active propagation of dendritic spikes was not altered. Since none of the three anesthetics tested abolished dendritic Ca 2+ spikes they can all be used for investigations of dendritic function in vivo, however it is vital in each case to take the specific effects of these anesthetics into account. -Critical frequency +24.0 ± 2.9% (n=16) * +16.4 ± 3.2% (n=12) * -22.2 ± 3.2% (n=14) * -ADP amplitude -10.7 ± 5.7% (n=16) * -54.0 ± 7.5% (n=12) * +151.0 ± 19.3% (n=14) *
Dendritic recordings:
-Ca 2+ spike amplitude -9.2 ± 5.5% (n=4) -12.8 ± 9.5% (n=3) +8.7 ± 6.5% (n=4) (SEM).
